Keyphrases
Anti-apoptotic
11%
BRCA Deficiency
11%
BRCA mutation Carriers
22%
BRCA1, BRCA2
11%
BRCA2
11%
Breast
100%
Breast Cancer
22%
Breast Cancer Susceptibility
11%
Breast Cancer Susceptibility Gene 1 (BRCA1)
100%
Breast Epithelial Cells
11%
Breast Epithelium
11%
Cell Death
11%
DNA Damage
55%
DNA Damage Response
100%
Epigenetic Modification
11%
Epigenetic Regulation
100%
Epithelial Cell Line
11%
Epithelial Cells
22%
Epithelial Tissue
22%
Gene Promoter
11%
Genetic Modification
11%
Genome Integrity
11%
Genome-wide Methylation
11%
Germline mutation
11%
High Risk
11%
High-risk Women
11%
Human Breast
11%
Human Mammary Epithelial Cells
100%
Induced Cell Death
11%
Mammary Epithelial Cells
11%
MCF10A
11%
Methylated Genes
11%
Methylation Profile
11%
Nonmalignant
11%
Normal Human
11%
Oncogenic Function
11%
Ovarian Cancer
11%
Prevention Strategies
11%
Pro-oncogenic
11%
Protective Effect
11%
Susceptibility to Cancer
11%
Tissue Differentiation
11%
Tissue Susceptibility
11%
Treatment Strategy
11%
Truncated Isoform
11%
ΔNp73
100%
Medicine and Dentistry
Antiapoptotic
14%
BRCA1
100%
BRCA2
14%
Breast Cancer
42%
Breast Epithelium
14%
Cancer Susceptibility
14%
Cell Death
28%
DNA Damage
71%
DNA Damage Response
100%
Epigenetic Modification
14%
Epithelial Cell
100%
Epithelial Cell Line
14%
Epithelium
28%
Gene Promoter
14%
Germline Mutation
14%
Malignant Neoplasm
14%
Methylation
14%
Ovarian Cancer
14%
P73
14%
Promoter Region
14%
Tissue Differentiation
14%
Biochemistry, Genetics and Molecular Biology
BRCA1
100%
BRCA2
14%
Cell Death
28%
DNA Damage
71%
DNA Damage Response
100%
Epigenetic Modification
14%
Epigenetics
100%
Genomics
28%
Germline Mutation
14%
Isoform
14%
Methylation
14%
Normal Human
14%
P73
14%
Pribnow Box
14%
Promoter Region
14%
Tissue Differentiation
14%